Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Equillium Q2 EPS $(0.41) Down From $(0.31) YoY

Equillium (NASDAQ:EQ) reported quarterly losses of $(0.41) per share. This is a 32.26 percent decrease over losses of $(0.31) per share from the same period last year.
byMichael Horton
August 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Equillium (NASDAQ:EQ) reported quarterly losses of $(0.41) per share. This is a 32.26 percent decrease over losses of $(0.31) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Amarin Announced New REDUCE-IT Data Showing Benefit Of VASCEPA/VAZKEPA In High-Risk Patients With A Recent Acute Coronary Syndrome Event

By Charles Gross
March 5, 12:03 PM
Amarin Corporation plc (NASDAQ: AMRN) today announced a new analysis from the VASCEPA/VAZKEPA (icosapent ethyl) cardiovascular outcomes REDUCE-IT study showing the effectiveness of VASCEPA®/VAZKEPA® in patients with recent acute coronary syndrome (<12 months before randomization).

AMRN